Robert P. Lenk
21Patents
14h-index
36Co-inventors
81Inventor score
Filing activity: Mar 24, 1983 → Mar 3, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4522803A | Stable plurilamellar vesicles, their preparation and use | Emerging Cross-Sectional Technologies | 276 | Expired |
| US5169637A | Stable plurilamellar vesicles | Emerging Cross-Sectional Technologies | 146 | Expired |
| US4981692A | Therapeutic treatment by intramammary infusion | Emerging Cross-Sectional Technologies | 123 | Expired |
| US5948441A | Method for size separation of particles | Emerging Cross-Sectional Technologies | 115 | Expired |
| US5030453A | Stable plurilamellar vesicles | Human Necessities | 102 | Expired |
| US5059591A | Drug preparations of reduced toxicity | Human Necessities | 100 | Expired |
| US5000958A | Enhancement of pharmaceutical activity | Emerging Cross-Sectional Technologies | 90 | Expired |
| US4897384A | Drug preparations of reduced toxicity | Human Necessities | 61 | Expired |
| US5616334A | Low toxicity drug-lipid systems | Emerging Cross-Sectional Technologies | 58 | Expired |
| US5811119A | Formulation and use of carotenoids in treatment of cancer | Performing Operations; Transporting | 47 | Expired |
| US5262168A | Prostaglandin-lipid formulations | Emerging Cross-Sectional Technologies | 24 | Expired |
| US5178875A | Liposomal-polyene preliposomal powder and method for its preparation | Emerging Cross-Sectional Technologies | 23 | Expired |
| US5366958A | Localized delivery using fibronectin conjugates | Emerging Cross-Sectional Technologies | 23 | Expired |
| US5082664A | Prostaglandin-lipid formulations | Emerging Cross-Sectional Technologies | 22 | Expired |
| US5925375A | Therapeutic use of multilamellar liposomal prostaglandin formulations | Emerging Cross-Sectional Technologies | 11 | Expired |
| US6200597A | Formulation and use of carotenoids in treatment of cancer | Human Necessities | 7 | Expired |
| US5830498A | Liposomal-polyene preliposomal powder and method for its preparation | Human Necessities | 3 | Expired |
| US8241648B2 | Amphiphilic or lipophilic polar functionalized fullerenes and their uses | Human Necessities | 3 | Active |
| US8563585B2 | Fullerene therapies for inflammation | General | 0 | Revoked |
| US8680125B2 | Fullerene therapies for inflammation | Chemistry; Metallurgy | 0 | Active |
| US9233177B2 | Metallofullerene contrast agents | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.